Chronic hepatitis B virus (HBV) infection remains a major cause of liver diseases, including cirrhosis and hepatocellular ...
Matthew Taylor likened his recently published work alongside doctoral student Gary Dunn to kicking over a rock. Once the ...
IB [email protected] ReiThera to Showcase Innovative Viral Vector Platforms at ESGCT 2025Rome, Italy – September 30 2025 – ReiThera Srl, the Italian leading Contract Development ...
News-Medical.Net on MSN
Discovery reveals hidden differences in herpes virus cultures
Matthew Taylor likened his recently published work alongside doctoral student Gary Dunn to kicking over a rock. Once the ...
Chronic hepatitis B (CHB) remains a formidable global health challenge, affecting over 250 million people and posing a significant risk for the ...
On Sept. 4, 2025, Health and Human Services Secretary Robert F. Kennedy Jr. is scheduled to testify before the Senate Finance Committee, where he is expected to face questions about his vaccine ...
FUJIFILM Biosciences launches BalanCD HEK293 Perfusion A to boost scalable viral vector production for gene therapy.
Deborah Fuller receives funding from the National Institutes of Health. She is co-founder and a scientific advisor for two biotech companies developing nucleic acid vaccine technologies that are not ...
EDITOR’S NOTE: The views expressed in this commentary are solely those of the writer. CNN is showcasing the work of The Conversation, a collaboration between journalists and academics to provide news ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback